ACS    Troponin is more useful than creatine kinase in predicting one-year mortality among acute coronary syndrome patients Eur Heart J (2004);25:2006-12 A. T. Yan, et al. One-year outcome of patients after acute coronary syndromes (from the Canadian Acute Coronary Syndromes Registry) Am J Cardiol (2004);94:25-9 A. T. Yan, et al. Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale Am Heart J (2004);148:764-75 G. W. Stone, et al. DECOPI (DEsobstruction COronaire en Post-Infarctus): a randomized multi-centre trial of occluded artery angioplasty after acute myocardial infarction Eur Heart J (2004);25:2187-94 P. G. Steg, et al. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE) Circulation (2004);109:494-9 P. G. Steg, et al. A dose-finding study of fondaparinux in patients with non-ST-segment elevation acute coronary syndromes: the Pentasaccharide in Unstable Angina (PENTUA) Study J Am Coll Cardiol (2004);43:2183-90 M. L. Simoons, et al. Prognostic relations between inflammatory markers and mortality in diabetic patients with non-ST elevation acute coronary syndrome Heart (2004);90:264-9 P. L. Sanchez, et al. Comparison of outcomes in acute coronary syndrome in patients receiving statins within 24 hours of onset versus at later times Am J Cardiol (2004);94:1166-8 F. A. Saab, et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes Jama (2004);292:1555-62 S. V. Rao, et al. Aspirin dose and six-month outcome after an acute coronary syndrome J Am Coll Cardiol (2004);43:972-8 M. J. Quinn, et al. Circulating endothelial cell count as a diagnostic marker for non-ST-elevation acute coronary syndromes Circulation (2004);110:1586-91 J. Quilici, et al. Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes: exploration of methods Circulation (2004);109:641-6 K. S. Pieper, et al. Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview Jama (2004);292:89-96 J. L. Petersen, et al. Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACS Eur Heart J (2004);25:1494-501 J. P. Ottervanger, et al. Clinical significance of a single measurement of troponin-I and C-reactive protein at admission in 1773 consecutive patients with acute coronary syndromes Am Heart J (2004);148:405-15 L. Oltrona, et al. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study Circulation (2004);110:1061-8 S. Okazaki, et al. Elevated troponin T levels and lesion characteristics in non-ST-elevation acute coronary syndromes Circulation (2004);109:465-70 K. Okamatsu, et al. Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes Circulation (2004);109:745-9 D. Mukherjee, et al. Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes Am Heart J (2004);147:246-52 D. K. McGuire, et al. There is no evidence for an increase in acute coronary syndromes after short-term abrupt discontinuation of statins in stable cardiac patients Circulation (2004);110:2333-5 M. P. McGowan Administration of eptifibatide to acute coronary syndrome patients receiving enoxaparin or unfractionated heparin: effect on platelet function and thrombus formation J Am Coll Cardiol (2004);43:966-71 E. I. Lev, et al. Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction Circulation (2004);109:855-60 C. D. Lee, et al. Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials Eur Heart J (2005);26:128-36 M. Labinaz, et al. Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Circulation (2004);110:386-91 S. Kinlay, et al. Prehospital therapy with the platelet glycoprotein IIb/IIIa inhibitor eptifibatide in patients with suspected acute coronary syndromes: the Bochum feasibility study Chest (2004);126:935-41 C. Hanefeld, et al. Importance of increasing age on the presentation and outcome of acute coronary syndromes in elderly patients J Am Coll Cardiol (2004);43:346-52 D. A. Halon, et al. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study Eur Heart J (2004);25:25-31 E. P. Gurfinkel, et al. Six-month outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (the Global Registry of Acute Coronary Events [GRACE]) Am J Cardiol (2004);93:288-93 R. J. Goldberg, et al. A simplified approach to the management of non-ST-segment elevation acute coronary syndromes Jama (2005);293:349-57 T. J. Gluckman, et al. Correlation of TIMI risk score with angiographic severity and extent of coronary artery disease in patients with non-ST-elevation acute coronary syndromes Am J Cardiol (2004);93:813-6 S. Garcia, et al. N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes Circulation (2004);110:128-34 M. Galvani, et al. Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE) Am Heart J (2004);147:42-8 M. I. Furman, et al. An international perspective on acute coronary syndrome care: insights from the Global Registry of Acute Coronary Events Am Heart J (2004);148:S40-5 K. A. Fox Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial Jama (2004);292:45-54 J. J. Ferguson, et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry Jama (2004);291:2727-33 K. A. Eagle, et al. Non-ST-elevation acute coronary syndrome in the elderly: treatment strategies and 30-day outcome Am Heart J (2004);147:830-6 S. De Servi, et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial Jama (2004);292:1307-16 J. A. de Lemos, et al. Subcutaneous enoxaparin with early invasive strategy in patients with acute coronary syndromes Am Heart J (2004);147:655-61 J. P. Collet, et al. Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes Circulation (2004);110:2361-7 J. P. Collet, et al. Dynamic prognostication in non-ST-elevation acute coronary syndromes: insights from GUSTO-IIb and PURSUIT Am Heart J (2004);148:62-71 W. C. Chang, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med (2004);350:1495-504 C. P. Cannon, et al. Elevations in troponin I after percutaneous coronary interventions are associated with abnormal tissue-level perfusion in high-risk patients with non-ST-segment-elevation acute coronary syndromes Circulation (2004);110:1592-7 L. Bolognese, et al. Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial Jama (2004);292:55-64 M. A. Blazing, et al. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative Jama (2004);292:2096-104 D. L. Bhatt, et al. Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non-ST-segment elevation acute coronary syndromes: a meta-analysis and review of the literature Am J Cardiol (2004);93:830-5 A. A. Bavry, et al.